Odontoprev SA
BOVESPA:ODPV3

Watchlist Manager
Odontoprev SA Logo
Odontoprev SA
BOVESPA:ODPV3
Watchlist
Price: 10.71 BRL 0.56% Market Closed
Market Cap: 5.9B BRL
Have any thoughts about
Odontoprev SA?
Write Note
Section:
 

Relative Value

The Relative Value of one ODPV3 stock under the Base Case scenario is 11.01 BRL. Compared to the current market price of 10.71 BRL, Odontoprev SA is Undervalued by 3%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ODPV3 Relative Value
Base Case
11.01 BRL
Undervaluation 3%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.6
P/S
P/S
Price to Sales
2.6
vs History
60
vs Industry
45
Median 3Y
2.8
Median 5Y
3
Industry
2.3
Forward
2.5
More Details
11.2
P/E
P/E
Price to Earnings
11.2
vs History
63
vs Industry
40
Median 3Y
11.8
Median 5Y
14.2
Industry
23.1
Forward
11
More Details
13.4
P/OCF
P/OCF
Price to OCF
13.4
vs History
46
vs Industry
20
Median 3Y
8.9
Median 5Y
13.9
Industry
14.2
More Details
16.4
P/FCFE
P/FCFE
Price to FCFE
16.4
vs History
46
vs Industry
19
Median 3Y
10
Median 5Y
17
Industry
20.1
More Details
4.7
P/B
P/B
Price to Book Value
4.7
vs History
22
vs Industry
19
Median 3Y
4.8
Median 5Y
4.9
Industry
2.2
More Details
2.3
EV/S
EV/S
Enterprise Value to Sales
2.3
vs History
60
vs Industry
45
Median 3Y
2.6
Median 5Y
2.9
Industry
2.4
Forward
2.2
More Details
7.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.5
vs History
9
vs Industry
29
Median 3Y
5.7
Median 5Y
5.6
Industry
5
More Details
7.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
7.3
vs History
65
vs Industry
41
Median 3Y
8
Median 5Y
9.3
Industry
12.7
Forward
7.2
More Details
7.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
7.9
vs History
66
vs Industry
41
Median 3Y
8.7
Median 5Y
10
Industry
17.1
Forward
7.7
More Details
11.9
EV/OCF
EV/OCF
Enterprise Value to OCF
11.9
vs History
46
vs Industry
21
Median 3Y
8.6
Median 5Y
12.6
Industry
14
More Details
14.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
14.6
vs History
46
vs Industry
19
Median 3Y
9.6
Median 5Y
15.4
Industry
18
More Details
3.1
EV/IC
EV/IC
Enterprise Value to IC
3.1
vs History
47
vs Industry
23
Median 3Y
3.3
Median 5Y
3.5
Industry
1.9
More Details

Multiples Across Competitors

ODPV3 Competitors Multiples
Odontoprev SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
BR
Odontoprev SA
BOVESPA:ODPV3
5.9B BRL 2.6 11.2 7.3 7.9
US
UnitedHealth Group Inc
NYSE:UNH
467.6B USD 1.2 32.7 13.9 15.7
US
Anthem Inc
LSE:0HG8
95.5B USD 0.5 14.9 10.6 12.2
US
Elevance Health Inc
NYSE:ELV
86B USD 0.5 13.4 9.7 11.2
US
Centene Corp
NYSE:CNC
30.7B USD 0.2 10 7.2 10.1
US
Humana Inc
NYSE:HUM
30.8B USD 0.3 22.7 8.5 10.9
US
Molina Healthcare Inc
NYSE:MOH
16.8B USD 0.4 14.7 5.5 6.1
US
Healthequity Inc
NASDAQ:HQY
8.3B USD 7.2 85.4 25 45.1
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
16.9B BRL 1 -39.4 6.9 15.6
US
Magellan Health Inc
F:MAH1
2.2B EUR 0.5 7.6 11 32.9
US
Clover Health Investments Corp
NASDAQ:CLOV
1.6B USD 1.1 -17.9 -18.6 -18.2
P/E Multiple
Earnings Growth P/E to Growth
BR
Odontoprev SA
BOVESPA:ODPV3
Average P/E: 23.6
11.2
14%
0.8
US
UnitedHealth Group Inc
NYSE:UNH
32.7
40%
0.8
US
A
Anthem Inc
LSE:0HG8
14.9
60%
0.2
US
Elevance Health Inc
NYSE:ELV
13.4
60%
0.2
US
Centene Corp
NYSE:CNC
10
51%
0.2
US
Humana Inc
NYSE:HUM
22.7
-31%
N/A
US
Molina Healthcare Inc
NYSE:MOH
14.7
56%
0.3
US
Healthequity Inc
NASDAQ:HQY
85.4
615%
0.1
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Negative Multiple: -39.4 N/A N/A
US
M
Magellan Health Inc
F:MAH1
7.6
N/A N/A
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -17.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
BR
Odontoprev SA
BOVESPA:ODPV3
Average EV/EBITDA: 10.6
7.3
17%
0.4
US
UnitedHealth Group Inc
NYSE:UNH
13.9
32%
0.4
US
A
Anthem Inc
LSE:0HG8
10.6
20%
0.5
US
Elevance Health Inc
NYSE:ELV
9.7
20%
0.5
US
Centene Corp
NYSE:CNC
7.2
6%
1.2
US
Humana Inc
NYSE:HUM
8.5
-31%
N/A
US
Molina Healthcare Inc
NYSE:MOH
5.5
39%
0.1
US
Healthequity Inc
NASDAQ:HQY
25
136%
0.2
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
6.9
72%
0.1
US
M
Magellan Health Inc
F:MAH1
11
N/A N/A
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -18.6 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
BR
Odontoprev SA
BOVESPA:ODPV3
Average EV/EBIT: 16.8
7.9
17%
0.5
US
UnitedHealth Group Inc
NYSE:UNH
15.7
36%
0.4
US
A
Anthem Inc
LSE:0HG8
12.2
31%
0.4
US
Elevance Health Inc
NYSE:ELV
11.2
31%
0.4
US
Centene Corp
NYSE:CNC
10.1
20%
0.5
US
Humana Inc
NYSE:HUM
10.9
-38%
N/A
US
Molina Healthcare Inc
NYSE:MOH
6.1
41%
0.1
US
Healthequity Inc
NASDAQ:HQY
45.1
174%
0.3
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
15.6
191%
0.1
US
M
Magellan Health Inc
F:MAH1
32.9
N/A N/A
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -18.2 N/A N/A

See Also

Summary
ODPV3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
ODPV3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ODPV3 stock valuation using valuation multiples.
Wall Street Estimates
ODPV3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ODPV3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.